ArticleBMC nutrition2026
Effectiveness of nutrition education program and omega-3 supplementation on body weight, liver enzyme, lipid profile among non-alcoholic fatty liver disease patients.
Article in BMC nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06627114 (Effectiveness of Nutrition Education Program and Omega-3 Supplementation on Body Weight, Liver Enzymes, Lipid Profile Among Non-Alcoholic Fatty Liver Disease Patients), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effectiveness of Nutrition Education Program and Omega-3 Supplementation on Body Weight, Liver Enzymes, Lipid Profile Among Non-Alcoholic Fatty Liver Disease Patients
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimNon-alcoholic fatty liver disease (NAFLD) represents a growing metabolic and hepatic health challenge worldwide, particularly in low- and middle-income regions such as Iraq. This study aimed to evaluate the safety and effectiveness of a combined nutrition education program and omega-3 fatty acid supplementation in improving anthropometric, biochemical, and hepatic outcomes among patients with NAFLD in Erbil City.
methodThis randomized controlled trial study was conducted from November 3rd, 2024 to March 3rd, 2025, at the outpatient clinic of Rizgary Teaching Hospital in Erbil City, Kurdistan Region, Iraq, using systematic sampling method. Data were collected using a structured questionnaire consisting of sociodemographic and clinical characteristics, anthropometric and biochemical measurements, the International Physical Activity Questionnaire (IPAQ), and dietary behavior scales. Statistical analyses were performed using IBM SPSS version 26 (IBM Corp., Armonk, NY).
resultsA total of 162 patients with non-alcoholic fatty liver disease (NAFLD) were included in the study. Both omega-3 supplementation and nutrition education interventions significantly improved anthropometric and biochemical parameters compared to baseline values. The nutrition education group achieved greater reductions in body weight (− 2.83 kg, p < 0.01), BMI (− 1.00 kg/m2, p < 0.01), and liver enzymes (ALT and AST, p < 0.01), along with improved lipid profiles and dietary behaviors. Total physical activity levels increased significantly in both intervention groups (p < 0.001). Hierarchical multiple regression identified nutrition education (β = 0.428, p < 0.001), omega-3 supplementation (β = 0.312, p < 0.001), physical activity change (β = 0.284, p < 0.001), and compliance (β = 0.258, p = 0.001) as key predictors of treatment success, collectively explaining 61% of the variance in outcomes.
conclusionsThe study demonstrated that a nutrition education and omega-3 supplementation program effectively improved hepatic function, lipid profile, and physical activity among patients with NAFLD in Erbil City. Integrating such low-cost, behaviorally oriented interventions into clinical practice may provide a sustainable approach for NAFLD management in resource-limited settings.
trial registrationThe clinical trial was prospectively registered at ClinicalTrials.gov (Identifier: NCT06627114; Registration date: October 2, 2024).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.